Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach.
Prajapati
Vimal
V
Division of Dermatology and Cutaneous Sciences, Department of Medicine, University of Alberta, Edmonton, AB.
Man
Jeremy
J
Brassard
Alain
A
D001172:Arthritis, Rheumatoid / Q000453:epidemiology; D003131:Combined Modality Therapy; D015897:Comorbidity; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology; D017511:Pyoderma Gangrenosum / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents